Treatment-guided endoscopy for moderate to severe esophageal dysplasia
Part of Cancer clinical trials.
This trial studies a newer approach to treat abnormal, precancer-like changes in the esophagus seen on a special endoscopy test using iodine. It may help prevent progression and spread by targeting moderate to severe dysplasia that appears in a specific, limited pattern.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 80 years old.
- Your endoscopy found at least one flat abnormal patch in the esophagus that turns iodine-sensitive (unstained lesion), with limited size and spread.
- Within the last 6 months, a biopsy confirmed moderate to severe precancer-like squamous dysplasia in the esophagus.
- Before treatment, scans/tests suggest there is no likely spread to lymph nodes.
- You must be willing to sign informed consent to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different combinations of treatments given before surgery for a type of esophageal cancer called squamous cell carcinoma. It aims to find the best approach to shrink the tumor and improve outcomes for patients whose cancer has not spread to distant organs.
This trial looks at a prevention treatment to stop esophagus abnormal growth (pre-cancer or very early cancer) from coming back after successful endoscopic submucosal dissection. It focuses on people whose esophagus lining shows a “speckled” pattern on a special iodine test, which may mean higher risk of recurrence.
This study compares two approaches for people with Barrett's esophagus and low-grade dysplasia: regular surveillance (monitoring with endoscopies) versus endoscopic treatment to remove the abnormal cells. It aims to see which approach is better at preventing progression to more serious conditions.
This study tracks patients having a procedure called endoscopic submucosal dissection to remove abnormal tissue from the esophagus. It aims to learn more about how well the procedure works and its safety.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial studies a specialized endoscopy procedure to remove larger abnormal growths in the upper digestive tract. It may help people whose lesion size and depth make certain removal techniques a better fit.
Hear when a new Esophageal Squamous Epithelium Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.